Northwestern Mutual Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.99K Hold
137
﹤0.01% 3243
2025
Q4
$6.23K Hold
137
﹤0.01% 3150
2025
Q3
$5.32K Sell
137
-1
-0.7% -$36 ﹤0.01% 3125
2025
Q2
$4.64K Sell
138
-648
-82% -$20.5K ﹤0.01% 3048
2025
Q1
$25K Hold
786
﹤0.01% 2428
2024
Q4
$30.5K Buy
786
+75
+11% +$3.15K ﹤0.01% 2362
2024
Q3
$32K Hold
711
﹤0.01% 2312
2024
Q2
$29.7K Sell
711
-1
-0.1% -$42 ﹤0.01% 2274
2024
Q1
$32.4K Buy
712
+1
+0.1% +$46 ﹤0.01% 2253
2023
Q4
$32.9K Sell
711
-2,215,614
-100% -$90.3M ﹤0.01% 2220
2023
Q3
$90.2M Buy
2,216,325
+509,442
+30% +$23.2M 0.12% 86
2023
Q2
$82.7M Sell
1,706,883
-160,999
-9% -$8.05M 0.11% 96
2023
Q1
$92M Buy
1,867,882
+194,858
+12% +$10M 0.13% 79
2022
Q4
$84.7M Buy
1,673,024
+38,582
+2% +$1.99M 0.13% 85
2022
Q3
$82M Buy
1,634,442
+530,612
+48% +$29.9M 0.14% 73
2022
Q2
$54M Buy
+1,103,830
New +$56M 0.09% 109

Other funds holding GNOM

Northwestern Mutual Wealth Management's GNOM Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q1 2026 at 137 shares worth $5.99K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

Northwestern Mutual Wealth Management first reported a position in GNOM in Q2 2022 and has held it in 16 quarters since. The position peaked at $92M in Q1 2023. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Northwestern Mutual Wealth Management held 137 shares of Global X Genomics & Biotechnology ETF worth $5.99K as of Q1 2026.
  • Northwestern Mutual Wealth Management left its Global X Genomics & Biotechnology ETF share count unchanged in Q1 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3243 holding.
  • Northwestern Mutual Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q2 2022 and has held it in 16 quarters since.
  • Northwestern Mutual Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $92M in Q1 2023.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.